Henschel Quoted on In re: Kubin

06 April 2009 IP Law360 News

Foley Partner Ric Henschel was quoted in an article that appeared on IP Law360 on April 6, 2009 titled “Fed Circ. Rejects Amgen Bid For DNA Patent.” Henschel provides insight into a federal appeals court decision to uphold the U.S. Patent and Trademark Office’s rejection of a DNA patent application filed by Amgen Inc., adding that the ruling was neither a clear nor satisfying outcome for the biotechnology community.

Insights

Blockchain: A Tool With a Future in Healthcare
18 July 2019
Health Care Law Today
A Review of Recent Whistleblower Developments
18 July 2019
Legal News: Whistleblower Developments
Do You Know What IMMEX Stands For?
16 July 2019
Dashboard Insights
Does The U.S. Need STRONGER Patents?
16 July 2019
PTAB Trial Insights
Review of 2020 Medicare Changes for Telehealth
11 December 2019
Member Call
2019 NDI Executive Exchange
14-15 November 2019
Chicago, IL
MAGI’s Clinical Research Conference
29 October 2019
Las Vegas, NV
Association for Corporate Counsel Annual Meeting 2019
27-30 October 2019
Phoenix, AZ